Research and Markets: Updated Saudi Arabia Pharmaceutical Market Report Examines the US$1.9 Billion Market

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/f3da68/the_pharmaceutical) has
announced the addition of the "The Pharmaceutical Market: Saudi Arabia" report
to their offering.

This report is ideal for executives wanting to understand the key drivers in the
pharmaceutical market and have access to a wealth of statistical data, including
five-year market projections. Included with the report are 3 free quarterly
updated outlook reports, enabling you to keep up to date with market
developments for a year.

Multinational manufacturers, who for years have enjoyed a relative free hand in
supplying the Saudi Arabian market with little obstruction, are beginning to
feel the heat, as the government starts to squeeze margins with annual price
cuts of 1% per annum which began in 2008.

Imported pharmaceuticals have, for a long time, dominated nearly 85% of the
market. Around ten multinational manufacturers have managed to command a 50%
share of the market in value terms, but this could very well change with the
price cuts. Saudi Arabia is the largest and richest of the Gulf States due to
its vast reserves of oil and natural gas. This means however, that the country's
wealth, and the economy, is dependent on the fluctuating price of oil.

There is little domestic production in Saudi Arabia, therefore the vast majority
of the market is provided by imports. However, Saudi Arabia imports a large
amount of semi-finished medicaments which are then re-labelled, repackaged and
exported. In 2006, imports were valued at US$1.9 billion, a rise of 12.5% over
2005. Germany and Switzerland were the leading suppliers. In contrast, exports
amounted to just US$102.1 million.

The pharmaceutical market is valued at US$1.9 billion in 2008, equal to US$77
per capita. Annual growth is predicted to be 5.1%, bringing the market to US$2.5
billion or US$87 per capita by 2013. In terms of value, the country is
comparable to Egypt.

Key Topics Covered:

EXECUTIVE SUMMARY

Domestic Manufacturing

Local Manufacturers

Multinational Manufacturers (Joint Venture Projects)

Biotechnology

Exports

Distributors

Healthcare Analysis

Demographics

Healthcare System

Health Expenditure

Healthcare Personnel

DIRECTORY

Companies Mentioned:

* SPIMACO
* Riyadh Pharma
* GlaxoSmithKline
* SAJAPHCO
* Tabuk Pharmaceutical Manufacturing Co.
* Jeddah BioCity

For more information visit
http://www.researchandmarkets.com/research/f3da68/the_pharmaceutical

Source: Espicom Business Intelligence Ltd

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax (USA): 646-607-1907
Fax (International): +353-1-481-1716

Copyright Business Wire 2009